ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,910Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 1677

$1.12M Total Retail Price of All Prescriptions

Rank: 53 out of 1677

867 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 867 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

25% of this provider’s 867 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 16,500 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
HYDROCODONE-ACETAMINOPHEN 1,321 769 S3 1 4
LEVOTHYROXINE SODIUM 971 690 2 5
SIMVASTATIN 817 586 3 1
LISINOPRIL 783 505 4 3
FUROSEMIDE 700 500 5 8
METFORMIN HCL 642 384 6 7
OMEPRAZOLE 617 460 7 6
AMLODIPINE BESYLATE 480 360 8 2
RANITIDINE HCL 464 257 9 18
NEXIUM 404 236 10 19
POTASSIUM CHLORIDE 386 285 11 14
GABAPENTIN 375 200 12 11
METOPROLOL TARTRATE 350 265 13 12
HYDROCHLOROTHIAZIDE 303 225 14 9
ZOLPIDEM TARTRATE 303 212 14 15
PRAVASTATIN SODIUM 276 169 16 10
CITALOPRAM HBR 273 195 17 22
SERTRALINE HCL 272 184 18 26
BENAZEPRIL HCL 269 189 19 53
PROAIR HFA 266 143 20 50
ATENOLOL 251 205 21 21
TRAMADOL HCL 235 140 22 16
CLOPIDOGREL 234 174 23 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 232 180 24 17
DICLOFENAC SODIUM 228 141 25 95
ATORVASTATIN CALCIUM 222 165 26 13
TRAZODONE HCL 219 164 27 37
CRESTOR 214 163 28 28
METOPROLOL SUCCINATE 209 149 29 23
ENALAPRIL MALEATE 201 169 30 82
CARVEDILOL 200 134 31 20
GLIMEPIRIDE 195 163 32 33
PANTOPRAZOLE SODIUM 191 128 33 46
FENOFIBRATE 189 120 34 48
ALLOPURINOL 180 133 35 31
PLAVIX 175 132 36 47
SPIRIVA 164 97 37 74
AMITRIPTYLINE HCL 161 91 R 38 63
MELOXICAM 158 100 39 27
FLUTICASONE PROPIONATE 156 82 40 29
DONEPEZIL HCL 155 155 41 30
SPIRONOLACTONE 154 102 42 88
POLYETHYLENE GLYCOL 3350 146 107 43 76
CYCLOBENZAPRINE HCL 143 98 R 44 52
TIZANIDINE HCL 136 45 45 108
CLONIDINE HCL 135 113 46 36
FAMOTIDINE 133 93 47 41
PREDNISONE 130 94 48 40
METHOCARBAMOL 127 34 R 49 169
FLUOXETINE HCL 126 66 50 49
LOSARTAN POTASSIUM 124 82 51 25
PROMETHAZINE HCL 123 71 R 52 64
DIGOXIN 113 85 53 71
GLIPIZIDE ER 113 93 53 78
LANTUS 112 86 55 44
CYMBALTA 112 52 55 58
ADVAIR DISKUS 112 54 55 54
LOVASTATIN 107 96 58 35
METFORMIN HCL ER 105 92 59 51
SULFAMETHOXAZOLE-TRIMETHOPRIM 104 75 60 85
TOPIRAMATE 103 66 61 181
INSULIN SYRINGE 103 72 61 72
ZETIA 103 66 61 75
BENAZEPRIL-HYDROCHLOROTHIAZIDE 100 70 64 139
AZITHROMYCIN 100 75 64 38
BACLOFEN 99 40 66 142
CIPROFLOXACIN HCL 98 79 67 57
AMOXICILLIN 96 65 68 94
AMLODIPINE BESYLATE-BENAZEPRIL 96 88 68 59
NAPROXEN 96 62 68 87
ESCITALOPRAM OXALATE 88 38 71 80
LIPITOR 86 53 72 101
VENTOLIN HFA 86 53 72 89
QUETIAPINE FUMARATE 85 0 74 77
PROPRANOLOL HCL 84 38 75 154
ROPINIROLE HCL 81 50 76 79
CEPHALEXIN 81 61 76 99
TAMSULOSIN HCL 78 23 78 34
ESTRADIOL 75 38 R 79 129
ALENDRONATE SODIUM 74 47 80 43
VERAPAMIL ER 73 53 81 86
AMOX TR-POTASSIUM CLAVULANATE 73 42 81 126
GLIPIZIDE XL 71 41 83 123
ENALAPRIL-HYDROCHLOROTHIAZIDE 71 71 83 283
TRIAMTERENE-HCTZ 71 47 83 61
PERPHENAZINE-AMITRIPTYLINE 70 70 R 86 328
JANUVIA 69 44 87 70
FOSINOPRIL SODIUM 68 46 88 221
DIOVAN 67 34 89 45
VENLAFAXINE HCL ER 64 38 90 92
DIOVAN HCT 64 59 90 66
KLOR-CON M20 64 38 90 65
DOXYCYCLINE HYCLATE 62 44 93 96
NORTRIPTYLINE HCL 62 54 93 206
NAMENDA 61 50 95 39
TERAZOSIN HCL 60 31 96 138
FEXOFENADINE HCL 59 45 97 311
BUSPIRONE HCL 59 41 97 120
ISOSORBIDE MONONITRATE ER 59 39 97 73
SINGULAIR 58 38 100 97
DICLOFENAC POTASSIUM 58 22 100 294
TRIAMCINOLONE ACETONIDE 57 36 102 134
ENDOCET 57 25 S2 102 114
HYDROXYZINE HCL 56 38 R 104 148
PHENYTOIN SODIUM EXTENDED 55 0 105 112
GLIPIZIDE 55 42 105 56
LABETALOL HCL 55 33 105 195
MECLIZINE HCL 54 51 108 110
MONTELUKAST SODIUM 53 33 109 174
VYTORIN 53 41 109 192
LANSOPRAZOLE 52 44 111 147
DILTIAZEM 24HR ER 52 50 111 144
RISPERIDONE 51 21 113 60
NABUMETONE 50 26 114 210
OXYBUTYNIN CHLORIDE 50 28 114 149
LEVOFLOXACIN 50 30 114 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 26, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.